Our corporate DNA is research and analysis. The entry-point to all our projects is evidence-based research and analysis, ensuring the latest and best understanding of the market, where our unbiased research takes us to the next step: understanding the future.

• Covering 150+ countries, we have identified, analyzed and standardized input from a large number of publicly available sources within regulatory, clinical, patents and value chains – generating critical evidence-based insights.
• Our evidence-based analysis is the pre-condition for any research, as it sets the stage and ensures high-quality discussions with contacts in the pharmaceutical and biotech industries.